SCHEMBL8934499

SCHEMBL8934499

COc1cc2ccc(=O)cc-2oc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.50
▸ PDE4A P27815 2/20 0.49
▸ ABCB1 P08183 4/20 0.46
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ KDM4E B2RXH2 4/20 0.46
▸ MAPK1 P28482 4/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ HSD17B10 Q99714 3/20 0.46
▸ CYP3A4 P08684 3/20 0.46
▸ MAPT P10636 3/20 0.46
▸ HPGD P15428 3/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ GLA P06280 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ ABCG2 Q9UNQ0 2/20 0.44
▸ TP53 P04637 1/20 0.44
▸ MDM2 Q00987 1/20 0.44
▸ CYP1B1 Q16678 2/20 0.43
▸ CYP1A1 P04798 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3125629 0.79 PDE4A (0.72) EGFRPDE4AABCB1MEN1KMT2A
SCHEMBL16788881 0.72 PDE4A (0.62) EGFRPDE4AABCB1MEN1KMT2A
SCHEMBL9618242 0.72 PDE4A (0.62) EGFRPDE4AABCB1MEN1KMT2A
SCHEMBL28350964 0.71 PDE4A (0.56) PDE4AABCB1MEN1KMT2AKDM4E
SCHEMBL24425880 0.67 EGFR (1.00) EGFRABCB1MEN1KMT2AKDM4E
SCHEMBL27915929 0.67 PDE4A (0.59) PDE4AABCB1MEN1KMT2AKDM4E
SCHEMBL6827893 0.66 PDE4A (0.57) PDE4AABCB1MEN1KMT2AKDM4E
SCHEMBL7654419 0.66 CYP1B1 (0.61) PDE4AABCB1MEN1KMT2AKDM4E
SCHEMBL28068547 0.65 LCK (0.44) PDE4AABCB1MEN1KMT2AKDM4E
SCHEMBL27898377 0.64 CYP1B1 (0.55) PDE4AABCB1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105530931-B Pharmaceutical combination for the treatment of melanoma 皮拉马尔企业有限公司 2019-11-08 — — CN disclosed
CN-105530931-A Pharmaceutical combination for the treatment of melanoma PIRAMAL ENTPR LTD 2016-04-27 — — CN disclosed
CN-104220066-A Pharmaceutical composition of paclitaxel and CDK inhibitor PIRAMAL LIFE SCIENCES LTD 2014-12-17 — — CN disclosed
CN-101472888-B Optically pure flavone derivatives for treating proliferative disorders and process for preparing same PIRAMAL LIFE SCIENCES LTD 2014-02-26 — — CN disclosed
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 — — WO disclosed
Send feedback